13ed8fe9 B0a7 4906 81a0 C2e253a3f180 01
Montelukast Sodium Tablet, Chewable
Product Images NDC 43063-381
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 43063-381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
13ed8fe9 B0a7 4906 81a0 C2e253a3f180 02
13ed8fe9 B0a7 4906 81a0 C2e253a3f180 03
This appears to be a chart or graph displaying mean percent change from baseline at different weeks (2, 6, 12, and 15) during treatment with either a placebo or montelukast sodium. Without more context or information, it is difficult to provide a more specific description or interpretation of the data.*
Image (43063381)
This is a description of a medication called Montelukast Sodium Chew. It comes in a pink oval shape and in three packages, each containing 30 chewable tablets with 4mg strength. The medication has a LOT number, expiration date (03/2020) and a NDC code (43063- 381-30). The package insert provides instructions for dosage and storage. The user should contact a doctor in case of side effects and report to the FDA as required. The packaging should be kept out of the reach of children. The document also lists an Organoleptic marking of 1079 A MG on the tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
